Early Warning Signs of Mania and Bipolar Relapse
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Early warning signs of mania often appear as changes in sleep, energy, speech, activity, judgment, or behavior that are unusual for a particular person. Sleeping substantially less without feeling tired, becoming markedly more talkative, taking on many projects, unusually intense confidence, irritability, racing thoughts, or impulsive spending may be especially important when several changes emerge together. Bipolar relapse can also begin with depressive symptoms, agitation, or mixed features. A concerning change deserves timely clinical attention even before it meets the duration or severity criteria of a full mood episode. Systematic review of relapse prodromes; NICE bipolar guideline.
The most useful question is not whether a person matches a generic checklist. It is: Is something changing from their usual stable pattern, is the change continuing or accelerating, and what did the beginning of their previous episodes look like? Recognizing that pattern early can support prompt assessment, reduce exposure to foreseeable risks, and activate an agreed treatment plan. Warning signs indicate a possibility of relapse; they are not a diagnosis or a reliable countdown to an episode. NICE recommendations on relapse plans.
For additional clinical context, see How Long Do Bipolar Episodes Last? Mania, Depression, and Recovery.
What are early warning signs of bipolar relapse?
A bipolar mood episode is a clinically significant period of changes in mood and activity associated with characteristic symptoms and, depending on the episode, impairment or other consequences. A relapse warning sign—sometimes called a prodrome—is a change occurring before a full new episode is established or while symptoms remain below an episode threshold. A person may notice it themselves; a partner, family member, or clinician may notice a change first. Episodes may also emerge without a recognizable warning period. NIMH bipolar disorder overview; Andrade-González and colleagues, systematic review.
For someone already diagnosed with bipolar disorder, these signs help distinguish a change in course from their usual baseline. For someone without a diagnosis, the same behavior can have many explanations. Sleep loss, medications, substance effects, physical illness, an anxiety disorder, attention-deficit/hyperactivity disorder (ADHD), or a stressful event may overlap with apparent manic symptoms. Clinicians examine duration, associated symptoms, functional consequences, previous episodes, medications, health conditions, and the overall history rather than identifying bipolar disorder from one behavior. NICE assessment recommendations. For the broader clinical framework, see Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment.
Early signs of mania and hypomania
Sleeping less without feeling tired
A reduced need for sleep is among the most recognizable warning patterns. Someone who ordinarily needs seven or eight hours may sleep only a few hours and still describe abundant energy, readiness to start the day, and little interest in resting. The important distinction is the perceived lack of need for sleep. Ordinary insomnia usually involves wanting to sleep and feeling fatigued, although real presentations can overlap. A new pattern of shortened sleep plus rising activity, accelerated thinking, or behavioral change calls for closer assessment. 2025 systematic review of sleep and mood; NIMH. For more on sleep and mood episodes, see Bipolar Disorder and Sleep: Mood Episodes, Circadian Rhythms, and Prevention.
A single late night is not a clinical episode. The level of concern increases when sleep shifts across consecutive nights, differs meaningfully from the person's own baseline, occurs without the expected exhaustion, or resembles the opening of a previous manic episode. Some people first notice increasingly irregular sleep and wake times rather than a dramatic reduction in total hours. Sleep itself is one component of a larger clinical picture; it cannot predict an episode by itself. Ulrichsen et al., 2025 systematic review.
Rising energy, activity, and goal-directed behavior
A person may begin several ambitious projects simultaneously, work late into the night, rearrange their environment, travel unexpectedly, contact many people, or become unusually restless. Increased energy can feel productive and rewarding at first. Clinicians and supporters pay attention to how far the activity departs from the individual's normal pace, whether they can stop or rest, and whether obligations, sleep, or judgment are being affected. In a 2020 systematic review of 22 studies involving 1,809 adults, increased energy, activity, and goal-directed behavior were frequently reported as manic or hypomanic relapse prodromes. Andrade-González et al., 2020.
More talkativeness, faster thoughts, and distractibility
Early changes can include speaking faster or more continuously, switching topics rapidly, sending an unusual volume of messages, feeling that ideas are arriving too quickly, or becoming increasingly distracted by new possibilities. The person may recognize an enjoyable sense of mental speed, while others notice that conversations are harder to follow or interrupt. The same person may also become impatient when others cannot keep up. These experiences gain clinical relevance through their pattern, accompanying changes, and effects on functioning. Systematic review of bipolar relapse prodromes; NIMH.
Unusually elevated confidence, expansive plans, or grandiosity
An early change may appear as unusually intense optimism, a powerful conviction that ordinary limits no longer apply, unrealistic commitments, or a sudden certainty about extraordinary abilities. The question is whether beliefs and decisions are distinctly different from the person's normal values and judgment, especially alongside sleep and activity changes. A surge of healthy confidence after good news does not establish mania. More concerning is a sustained, escalating cluster involving overactivity, impaired judgment, or beliefs becoming implausible or fixed. NIMH; NICE guidance on risk assessment.
Irritability, agitation, or conflict
Mania can present through irritable or expansive mood, and early changes are not always cheerful. An individual may become unusually argumentative, impatient, easily overstimulated, or intensely frustrated by perceived obstacles. Increased irritability alone has low specificity: pain, stress, anxiety, sleep deprivation, substance effects, and many other factors can produce it. A clinician asks whether irritability accompanies a broader episodic rise in energy and other manic symptoms. NIMH symptom overview; Andrade-González et al., 2020.
Impulsivity, spending, sexual behavior, and risk-taking
Unusually large purchases, investments that disregard prior financial boundaries, risky driving, abrupt career decisions, increased sexual interest or activity, and other disinhibited behavior can be especially consequential. Such actions may emerge before a person recognizes their change in mood. Their meaning depends on context and baseline, but an abrupt cluster with reduced sleep and escalating energy should prompt timely contact with a treatment team. NICE explicitly recommends discussing risks involving spending, driving, exploitation, relationships, and sexual health during bipolar assessment and planning. NICE CG185; systematic review.
How early signs differ from a manic or hypomanic episode
Mania is a distinct period of abnormally elevated, expansive, or irritable mood and increased energy or activity with additional characteristic symptoms. Standard diagnostic criteria generally require at least one week of the syndrome, or a shorter period when hospitalization is necessary; marked impairment, psychotic features, or hospitalization indicate a manic episode. Hypomania involves a recognizable change from usual functioning lasting at least four consecutive days, observable by others, without the marked impairment, psychosis, or hospitalization characteristic of mania. These are clinician-applied diagnostic thresholds, not waiting periods for help. NIMH bipolar disorder overview; NICE specialist assessment guidance.
Bipolar I disorder requires a history of at least one manic episode; bipolar II disorder involves hypomania and major depressive episodes without a history of full mania. Hypomania can still destabilize work, relationships, routines, and judgment, and bipolar II disorder can impose substantial depressive burden. A person developing dangerous symptoms should receive assessment immediately rather than tracking days until a diagnostic cutoff. Bipolar disorder classification and diagnosis require longitudinal clinical evaluation. NIMH; VA/DoD 2023 clinical practice guideline.
Early warning signs of bipolar depression
Relapse prevention must address depression as well as mania. Someone who previously experienced bipolar depression may notice a progressive reduction in interest, motivation, pleasure, or energy; withdrawal from usual relationships; growing hopelessness; changes in concentration; or difficulty keeping up with daily responsibilities. Their sleep may become longer, and waking may become harder. In the adult prodrome review, loss of interest and excessive sleep were more closely associated with depressive relapse than manic relapse. These clues are not specific enough to establish an episode alone. Andrade-González et al., 2020.
Longitudinal sleep research supports paying attention to direction of change while resisting simplistic predictions. A 2025 systematic review of 13 studies found that longer sleep and later waking were often followed by more depressive mood, whereas shorter or earlier sleep patterns were more often associated with elevated mood. The investigators emphasized substantial heterogeneity and limitations that prevented a quantitative meta-analysis. A person's own history is therefore more informative than an internet threshold such as a fixed number of hours. Ulrichsen et al., 2025.
Depressive warning signs become urgent when they include suicidal thoughts, inability to care for basic needs, or severe deterioration. They also need professional evaluation because depression in someone with bipolar disorder can affect medication decisions differently from unipolar major depression. The evidence and treatment options for bipolar depression cannot simply be transferred from interventions used for acute mania. VA/DoD guideline, 2023; CANMAT/ISBD treatment update.
Mixed features: when activation and depression appear together
A particularly concerning presentation involves depressive mood, despair, or agitation alongside activation such as racing thoughts, restlessness, decreased sleep, or increased energy. Clinicians assess whether a mood episode has mixed features and examine suicide risk, substance use, medications, and other causes. A person may say they feel exhausted emotionally but physically driven, unable to settle, or overwhelmed by intense thoughts. These symptoms warrant timely professional assessment, especially if impulsivity or suicidal thinking accompanies them. The exact specifier depends on the documented episode and clinical criteria. NIMH; NICE crisis and risk guidance. For diagnosis and risks of these presentations, see Bipolar Disorder With Mixed Features: Symptoms, Risks, and Diagnosis.
Mixed symptoms can be mistaken for anxiety, ordinary irritability, or insomnia when the clinician lacks a full mood history. Their detection requires careful questioning about duration, simultaneous symptom domains, medication or substance effects, and the individual's previous episodes. For safety, the appropriate response is an assessment of the whole clinical picture, including current functioning and risk, rather than automatically labeling an agitated person manic. NICE CG185 clinical assessment.
How long before a relapse do warning signs appear?
There is no dependable interval that applies to everyone. Prodromal changes may develop over days or weeks; some episodes have a longer or less distinct buildup, while others escalate quickly or appear to have no identifiable warning phase. Earlier research suggests a period of weeks in some patients, but the duration differs across individuals, phases, episodes, and research methods. Retrospective reports can be affected by memory of the episode itself. It is more useful to agree in advance what changes merit same-day contact than to wait for a particular number of days. Andrade-González et al., systematic review; Perry et al., 1999 randomized trial.
A person's early-warning pattern may become clearer after reviewing several past episodes with a clinician and a trusted supporter. The preceding signs of mania can differ from those of depression, and two manic episodes may not be identical. A recent bereavement, high-pressure work period, travel, infection, missed medication, or loss of sleep may also change the presentation. These contextual factors help guide assessment; they should never be treated as proof that a relapse will occur. NICE individualized assessment and care plans.
What makes an early warning sign more clinically important?
Clinicians look for combinations rather than isolated symptoms. The most informative pattern involves a clear departure from baseline, persistence or progression, co-occurring changes across sleep, energy, speech, behavior, and thinking, and resemblance to the person's known previous episode signature. Functional consequences—such as missed work, unsafe decisions, sudden financial commitments, or inability to sleep—raise concern. Reports from someone who knows the person's stable behavior can add information with permission and respect for their autonomy. NICE assessment and risk assessment.
Two distinct kinds of information are valuable. Observations describe what is occurring now: for example, 'three nights of four hours of sleep with unusually high energy and continuous messaging.' Historical comparison asks whether this resembles the start of a past episode, whether any factors have changed, and how similar changes resolved. This makes discussion with a clinician more specific while avoiding a self-diagnosis based on an online symptom list. NICE CG185.
Triggers, vulnerabilities, and circumstances that can complicate recognition
Sleep disruption, travel, work schedules, and stress
Disruptions to sleep–wake timing deserve attention because sleep and circadian changes are connected to mood instability in bipolar disorder. Shift work, travel across time zones, several late nights, caregiving demands, and intense social schedules can complicate recovery routines. However, the direction of causation can be difficult to determine: reduced sleep may contribute to vulnerability, be an early symptom of emerging mania, or both. The practical approach is to protect regular sleep and alert the clinician to a significant change. Ulrichsen et al., 2025; NICE long-term management advice.
Medication, substances, and physical health
Changes in prescribed treatment, inconsistent access to medication, alcohol or stimulant use, and some medications used for other conditions can complicate mood stability and produce symptoms resembling activation. Medical issues, including thyroid disorders, also require consideration when new mood and energy changes appear. Tell a clinician about all prescribed medicines, supplements, substances, recent illnesses, and significant changes in sleep. Medication decisions should be made with the prescriber; abruptly stopping a maintenance treatment can create additional risk. NICE differential diagnosis and long-term treatment recommendations; VA/DoD 2023 guideline.
Individual patterns and differing populations
The same warning-sign list performs differently across ages and contexts. Changes in childhood or adolescence must be assessed in relation to development, chronic attention or behavioral symptoms, trauma, sleep, substances, and family circumstances. Older adults may have medical or medication-related contributors that require special consideration. Pregnancy and the postpartum period require specialized psychiatric and obstetric planning, particularly when sleep is disrupted or medication risks are changing. These situations call for clinicians experienced with the relevant population rather than automatically applying evidence from nonpregnant adults. NICE sections on children, medication, and pregnancy; VA/DoD guideline.
What to do when early warning signs of mania appear
A useful response depends on severity and any existing individualized crisis plan. If several characteristic changes are emerging—particularly reduced need for sleep with accelerating energy or impulsivity—contact the treating psychiatrist, mental health team, or appropriate urgent assessment service promptly, ideally the same day when the pattern is clear or intensifying. Describe specific changes, their duration, previous similar episodes, prescribed treatments, and immediate safety concerns. If a clinician has already given a written action plan for these situations, follow its agreed instructions. NICE individualized risk and relapse plan.
Protect sleep and reduce unnecessary stimulation
Re-establish predictable bedtime and waking routines where possible, keep the environment calm, and consider postponing optional late-night plans, excessive social commitments, and high-stimulation activities. Avoid alcohol and recreational stimulants and discuss caffeine or medication changes with the clinician as appropriate. These steps support clinical care and monitoring, but they cannot reliably stop an evolving episode on their own. NICE recommends access to calming environments and reduced stimulation in mania or hypomania. NICE CG185 mania/hypomania management.
Temporarily protect high-stakes decisions
If judgment or impulsivity appears to be changing, defer large purchases, new loans, major relationship decisions, risky driving, abrupt travel, and irreversible professional commitments until the person has been assessed and symptoms stabilize. The practical safeguards should be agreed in advance whenever possible, with clear boundaries and proportionate steps that preserve dignity. NICE explicitly advises avoiding important decisions during mania or hypomania and assessing risks around finances, driving, and exploitation. NICE recommendations.
Contact agreed supports and document observable changes
A trusted supporter may help arrange an appointment, reduce practical demands, notice further escalation, and support sleep routines. With the person's permission, share factual observations rather than judgments about character. Write down the change in sleep hours, activity, speech, spending, mood, medications, and the timing of concerns so the clinician can reconstruct the course. The goal is coordinated care, not continuous policing. An advance agreement about who may be contacted and what information may be shared makes this process clearer. NICE collaborative assessment and risk planning.
Use a medication action plan only as specifically prescribed
Some individualized plans include clinician-authorized adjustments or a previously prescribed rescue medication for defined warning signs. These arrangements require an explicit medical instruction about the exact circumstances, drug, and follow-up. Do not start an antipsychotic, increase a mood stabilizer, take someone else's medication, or stop prescribed treatment based on an internet checklist. Medication for acute mania, bipolar depression, and long-term prevention follows different evidence and monitoring requirements. NICE relapse-action protocol; CANMAT/ISBD, 2023.
When warning signs require urgent or emergency help
Urgent specialist evaluation is appropriate if mania seems to be developing rapidly, a person has almost stopped sleeping and is increasingly activated, judgment is severely impaired, or behavior is creating immediate financial, interpersonal, or physical danger. Psychotic symptoms—such as fixed false beliefs or hallucinations—also require prompt professional assessment. Severe agitation, profound depression, inability to meet basic needs, or escalating suicidal thinking heighten urgency. Where there is imminent danger to anyone or the person cannot remain safe, contact emergency services or go to the nearest emergency department. NICE recommendation 1.2.2 and crisis section; VA/DoD bipolar guideline. For clinical context about psychotic symptoms, see Psychotic Symptoms in Bipolar Disorder: Recognition and Clinical Care.
In the United States, 988 connects people experiencing suicidal distress or a mental health crisis with the 988 Suicide & Crisis Lifeline; call 911 for an immediate life-threatening emergency. Outside the United States, use the local crisis service or emergency number. A person experiencing psychosis or marked loss of judgment may have limited insight into the danger, so family members and caregivers may need to seek professional advice about urgent assessment. Emergency evaluation is a clinical response to risk, not a conclusion about a person's character. 988 Lifeline; NICE clinical risk guidance.
How to build a personalized bipolar early-warning plan
A relapse plan is most useful when written during a period of relative stability with the person, clinician, and any trusted supporters the person chooses. It should identify their usual stable pattern, their early signs of mania and depression, warning signs of increasing risk, possible triggers, coping approaches, contact routes, prescribed response instructions, and crisis options. An actionable plan states what will happen when a specified change occurs; a generic encouragement to 'watch your mood' leaves too much to decide during an emerging episode. NICE sections 1.4.1, 1.7.4 and 1.9.4.
Establish the personal baseline
Record typical sleep duration and timing, work and study patterns, communication style, activity, social interests, and usual emotional range during a stable period. It may also help to identify residual symptoms that occur even outside major episodes so ordinary variation does not trigger unnecessary alarm. The baseline belongs to the person and will differ across individuals. Changes in functioning and context matter more than matching a universal numeric score. NICE individualized care planning.
Describe a warning pattern using real examples
Write a brief description of how past episodes actually began: 'I start sleeping four hours, become certain I can finish several new businesses, and send dozens of messages after midnight,' or 'I begin sleeping much longer, stop answering friends, and lose interest in meals and work.' These are illustrative examples, not diagnostic thresholds. If previous episodes began differently, document several patterns. The 2020 prodrome review supports the value of identifying recurrent observable changes while also finding significant variability and limited specificity. Systematic review.
Agree on a graded response
A practical plan distinguishes a mild deviation that calls for closer observation from a clear combination of escalating symptoms that calls for prompt clinician contact, and from symptoms that require an urgent service or emergency evaluation. For example, a single night of reduced sleep might prompt review of routines; repeated short sleep with unusually high energy and spending could trigger same-day contact; psychosis, dangerous behavior, or inability to remain safe requires immediate help. These examples illustrate a decision structure, not standardized medical instructions. Individual thresholds should be confirmed with the treatment team. NICE risk management and crisis plan.
Name the people, numbers, and permissions
A written plan should identify the main clinician, out-of-hours or urgent service, local emergency resources, and one or two supporters the person trusts. Specify when those supporters may contact a professional or family member and how to handle disagreements sensitively. Include any clinician-approved medication instructions and the review date. Share copies with everyone who is meant to use it, consistent with the person's consent and safety needs. Update the plan after a relapse, a treatment change, or a major shift in daily circumstances. NICE CG185.
Mood and sleep tracking: useful observations, real limitations
A brief sleep and mood record can reveal a developing pattern that is difficult to recognize in the moment. Useful entries may include bedtime, wake time, estimated sleep, energy, activity, mood, irritability, medication adherence, substance use, and significant events. Tracking need not be elaborate: the best method is one the person can sustain without distress or excessive checking. Recording the personal baseline helps distinguish a change from a longstanding habit. The purpose is to improve conversations and decisions with clinicians, not to generate a diagnosis from an app. NICE psychoeducational interventions; Ulrichsen et al., 2025.
The current evidence is promising but mixed. A 2025 systematic review found associations between sleep changes and subsequent mood states, while noting high heterogeneity across studies. A small 2025 longitudinal study using smartphone and sensor data found several signals preceding episodes, but none of the tested predictors reached its predefined threshold for real-world clinical utility. Monitoring cannot substitute for clinical assessment, and alerts may create false reassurance or unnecessary anxiety. Decide with the care team what action a meaningful change should trigger. Sleep systematic review; smartphone prediction study.
What does research show about recognizing warning signs?
There is good clinical rationale for including early warning signs in ongoing bipolar care, and some randomized trials support structured recognition and response as part of treatment. In one 1999 trial of 69 people with bipolar disorder, a program teaching patients to recognize early symptoms and seek prompt care delayed manic relapse and improved some functional outcomes, while it did not demonstrate a comparable benefit for depressive relapse. This trial was relatively small and should not be interpreted as proof that self-monitoring alone prevents bipolar episodes. Perry et al., BMJ randomized trial.
A 2007 Cochrane review found that psychological interventions incorporating early-warning recognition alongside usual care tended to improve time to recurrence and some other outcomes, but the authors noted incomplete outcome reporting and difficulty isolating which components were responsible. A 2025 Cochrane publication on this question is a review protocol, not a completed new effectiveness review; it cannot be cited as updated proof of benefit. The clinical recommendation remains to integrate recognition with appropriate ongoing medication, psychoeducation, psychotherapy when indicated, and a clinician-directed relapse plan. Morriss et al., 2007 Cochrane review; NICE guideline.
Research into early-warning signs also has methodological limits. Some studies ask people to recall changes before a previous episode; memory may be influenced by what happened later. Sample sizes, episode definitions, observation schedules, and monitoring measures vary. A sign common in people who later relapse can also occur in people who remain well. For this reason, a research association does not automatically translate into an accurate individual prediction. Personalized clinical review and safety-oriented action thresholds remain central. Andrade-González et al., 2020; Ulrichsen et al., 2025.
The role of ongoing treatment and medication safety
Warning-sign recognition complements long-term bipolar treatment. Clinicians select maintenance strategies based on the person's diagnosis, episode polarity, recurrence history, effectiveness, preferences, comorbidities, adverse effects, and monitoring needs. Medication choices for acute mania, bipolar depression, and maintenance are not interchangeable. Stopping prescribed mood-stabilizing treatment on one's own can increase the chance of instability; concerns about adverse effects or possible pregnancy should prompt an individualized medical discussion instead. CANMAT/ISBD 2023 update; VA/DoD 2023 guideline. See also Bipolar Disorder Treatment: Medication, Therapy, and Long-Term Care.
Lithium requires kidney and thyroid assessment, serum-level monitoring, attention to hydration, and review of interacting medicines including some nonsteroidal anti-inflammatory drugs. Lamotrigine requires careful initiation and rapid clinical review of a new rash, especially during dose increases; it is not a standard treatment for acute mania. Valproate carries important reproductive and fetal risks and requires specialist prescribing decisions. Antipsychotic medicines differ in their indications and require monitoring for adverse effects that can include metabolic changes. Antidepressants can be associated with mood switching in susceptible patients and require phase-specific clinical judgment. These are safety considerations, not directions to alter a regimen. NICE prescribing and monitoring recommendations; CANMAT/ISBD 2023.
If a person has missed doses, notices side effects, runs out of medication, or suspects activation after a prescription change, the appropriate next step is to contact their prescriber or pharmacist promptly for specific advice. A prewritten medication contingency plan may include instructions unique to that person, but the existence of a warning sign never establishes which drug or dose should be used. The goal of early recognition is to get professional decisions made earlier, while symptoms are still more manageable. NICE CG185 clinical management.
How family members and partners can help without turning every mood change into a symptom
Support works best when it is collaborative. During a stable period, ask the person which past changes they find meaningful, how they want concerns raised, whom they trust to contact a clinician, and what practical steps are welcome. When warning signs appear, begin with concrete observations: 'I've noticed you're sleeping much less and starting several things at once; is this similar to what happened before?' Listen to the response and offer practical support with appointments, routines, or daily tasks. Framing a disagreement as proof of mania can damage trust and obscure the clinical facts. NICE guidance on collaborative planning and carers.
Boundaries matter for everyone involved. Supporters can avoid participating in unsafe spending or high-risk plans, encourage clinical contact, and act on a preagreed crisis plan. They should not take over ordinary choices simply because a person has a bipolar diagnosis. If there is a credible immediate safety risk, seeking urgent assistance is appropriate even when the person disagrees with the assessment of danger. Family-focused psychoeducation and structured psychological interventions can help establish realistic roles and communication strategies alongside continuing treatment. NICE psychological and family intervention recommendations.
Mistaking other experiences for manic relapse
A short-lived rise in happiness, excitement after success, intense interest in a new hobby, ordinary changes in mood, or an occasional poor night's sleep does not establish mania. ADHD can involve persistent distractibility and impulsivity, whereas bipolar symptoms are evaluated for sustained episodic changes from baseline. Anxiety, insomnia, grief, depression, substance effects, thyroid disease, and medication reactions also need consideration. Clinicians assess these possibilities and can identify conditions that co-occur. A symptom checklist or screening questionnaire cannot make this differential diagnosis. NICE differential diagnosis and screening guidance.
Likewise, a person may become highly productive or socially active without developing a mood disorder. The clinical distinction is informed by accompanying sleep and energy changes, unusually altered behavior and judgment, duration, recurrence, and effects on functioning. Bipolar II is not simply mild bipolar I, and periods of hypomania should not be assumed harmless. When a person has a prior diagnosis and a known warning pattern, the safest question is whether their course is changing in a way that warrants professional review. NIMH; VA/DoD guideline.
Frequently asked questions
What is usually the first sign of mania?
There is no universal first sign. Reduced need for sleep, a noticeable increase in energy or activity, faster speech, racing thoughts, irritability, or unusually expansive plans may appear early. Sleep changes are particularly useful for many people, but their meaning depends on the individual's baseline and the presence of other changes. An unfamiliar or escalating pattern merits clinician contact without waiting for a textbook symptom sequence. Andrade-González et al., 2020; Ulrichsen et al., 2025.
Can mania start without euphoria?
Yes. Irritability or agitation may accompany elevated activity and energy, and mood can feel unpleasant rather than euphoric. Mixed features further complicate how someone describes their experience. Assessment considers the full cluster, duration, course, risk, and alternative explanations. NIMH bipolar disorder information.
How little sleep is a warning sign?
No universal number of hours predicts mania. A meaningful departure from personal sleep needs—particularly when accompanied by little fatigue and growing activation—is more informative than a fixed cutoff. Persistent severe sleep reduction with behavioral changes deserves prompt evaluation. 2025 sleep systematic review.
Can a person recognize their own manic relapse?
Many people learn to identify characteristic early changes, especially with a written plan and support from clinicians or trusted observers. Recognition can also be difficult when symptoms alter confidence, insight, or judgment. A structured plan reduces the need to improvise while unwell and allows clinical input when the person or another agreed observer becomes concerned. Perry et al., 1999; NICE crisis planning.
Can mania be prevented once early warning signs appear?
Early recognition creates an opportunity for clinical assessment and timely response, and some trials show benefit from training and coordinated care. It does not guarantee prevention. A new episode may progress despite appropriate treatment, and people should not interpret a relapse as a personal failure. Maintain an individualized care plan and seek professional advice about changes rather than attempting unprescribed treatment. Morriss et al., 2007; NICE recommendations.
Can depression be a sign of bipolar relapse?
Yes. Recurrence may take the form of bipolar depression, hypomania, mania, or episodes with mixed features. Emerging withdrawal, loss of interest, longer sleep, or loss of functioning can signal depressive worsening, though each symptom has multiple possible causes. Suicidal thinking or severe decline calls for urgent support. Systematic review; VA/DoD guideline.
Should a person with bipolar disorder stop their medication if they feel energetic or unusually well?
No change to a prescribed regimen should be made on the basis of feeling better or seeing an online warning list. Contact the prescribing clinician about emerging activation, missed doses, side effects, or concerns with treatment. The safest response depends on the medication, episode phase, and person's health and treatment history. NICE long-term care and stopping treatment.
Do mood-tracking apps or smartwatches reliably predict relapse?
No current consumer monitoring method is established as a stand-alone clinical predictor for an individual. Logs of sleep and activity can help conversations with a clinician, but even promising smartphone research has failed to reach specified thresholds for routine prediction. Use digital tools with a clear purpose, consent, and an agreed response plan. 2025 digital phenotyping study.
When should someone seek help rather than continue watching symptoms?
Seek prompt clinical advice when several characteristic changes are developing or escalating, especially with markedly reduced sleep, unusual impulsivity, or impaired functioning. Use urgent or emergency services for psychosis, serious risk-taking, severe mania, suicidality, or inability to stay safe. Do not wait for a seven-day manic or four-day hypomanic diagnostic duration. NICE urgent assessment guidance.
Related Articles
References
988 Suicide & Crisis Lifeline. (n.d.). Get help. https://988lifeline.org/get-help/
Andrade-González, N., Álvarez-Cadenas, L., Saiz-Ruiz, J., & Lahera, G. (2020). Initial and relapse prodromes in adult patients with episodes of bipolar disorder: A systematic review. European Psychiatry, 63(1), e12. https://doi.org/10.1192/j.eurpsy.2019.18
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009
Ludwig, V. M., Bittendorf, C. A., Reinhard, I., Neubauer, A. B., Mennigen, E., Mühlbauer, E., Severus, W. E., Bauer, M., & Ebner-Priemer, U. W. (2025). Early warning signals of bipolar relapse: Investigating critical slowing down in smartphone data. Journal of Affective Disorders, 391, Article 119972. https://doi.org/10.1016/j.jad.2025.119972
Morriss, R., Faizal, M. A., Jones, A. P., Williamson, P. R., Bolton, C., & McCarthy, J. P. (2007). Interventions for helping people recognise early signs of recurrence in bipolar disorder. Cochrane Database of Systematic Reviews, CD004854. https://doi.org/10.1002/14651858.CD004854.pub2
National Institute for Health and Care Excellence. (2014; updated September 2, 2025). Bipolar disorder: Assessment and management (CG185). https://www.nice.org.uk/guidance/cg185/chapter/recommendations
National Institute of Mental Health. (n.d.). Bipolar disorder. https://www.nimh.nih.gov/health/publications/bipolar-disorder
Perry, A., Tarrier, N., Morriss, R., McCarthy, E., & Limb, K. (1999). Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ, 318, 149–153. https://doi.org/10.1136/bmj.318.7177.149
Ulrichsen, A., Tröger, A., Jauhar, S., Severus, E., Bauer, M., & Cleare, A. (2025). Do sleep variables predict mood in bipolar disorder: A systematic review. Journal of Affective Disorders, 373, 364–373. https://doi.org/10.1016/j.jad.2024.12.098
U.S. Department of Veterans Affairs and U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for the management of bipolar disorder. https://www.healthquality.va.gov/guidelines/MH/bd/index.asp